BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35091463)

  • 1. Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study.
    Paulshus Sundlisæter N; Sundin U; Aga AB; Sexton J; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Lillegraven S
    RMD Open; 2022 Jan; 8(1):. PubMed ID: 35091463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
    Paulshus Sundlisæter N; Aga AB; Olsen IC; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
    Ann Rheum Dis; 2018 Oct; 77(10):1421-1425. PubMed ID: 29934373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol.
    Paulshus Sundlisæter N; Olsen IC; Aga AB; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
    Rheumatology (Oxford); 2018 Nov; 57(11):2022-2031. PubMed ID: 30053199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
    Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions.
    Studenic P; Smolen JS; Aletaha D
    Ann Rheum Dis; 2012 Oct; 71(10):1702-5. PubMed ID: 22736085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?
    Studenic P; Felson D; de Wit M; Alasti F; Stamm TA; Smolen JS; Aletaha D
    Ann Rheum Dis; 2020 Apr; 79(4):445-452. PubMed ID: 32024651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.
    Rintelen B; Sautner J; Haindl P; Mai H; Brezinschek HP; Leeb BF
    J Rheumatol; 2013 Apr; 40(4):394-400. PubMed ID: 23378466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision.
    Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
    Arthritis Rheumatol; 2023 Jan; 75(1):15-22. PubMed ID: 36274193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.
    Shidara K; Nakajima A; Inoue E; Hoshi D; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
    J Rheumatol; 2017 Feb; 44(2):147-153. PubMed ID: 27909083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision.
    Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
    Ann Rheum Dis; 2023 Jan; 82(1):74-80. PubMed ID: 36280238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
    Masri KR; Shaver TS; Shahouri SH; Wang S; Anderson JD; Busch RE; Michaud K; Mikuls TR; Caplan L; Wolfe F
    J Rheumatol; 2012 Jun; 39(6):1139-45. PubMed ID: 22589262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.
    Uhlig T; Lie E; Norvang V; Lexberg ÅS; Rødevand E; Krøll F; Kalstad S; Olsen IC; Kvien TK
    J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME; Hsia E; Aletaha D
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.
    Balogh E; Madruga Dias J; Orr C; Mullan R; Harty L; FitzGerald O; Gallagher P; Molloy M; O'Flynn E; Kelly A; Minnock P; O'Neill M; Moore L; Murray M; Fearon U; Veale DJ
    Arthritis Res Ther; 2013 Dec; 15(6):R221. PubMed ID: 24365061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria.
    Kuriya B; Sun Y; Boire G; Haraoui B; Hitchon C; Pope JE; Thorne JC; Keystone EC; Bykerk VP;
    J Rheumatol; 2012 Jun; 39(6):1155-8. PubMed ID: 22505708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis.
    Mueller RB; Schiff M; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
    Clin Rheumatol; 2015 Jan; 34(1):51-9. PubMed ID: 25024096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High patient global assessment scores in patients with rheumatoid arthritis otherwise in remission do not reflect subclinical inflammation.
    Brites L; Rovisco J; Costa F; Freitas JPD; Jesus D; Eugénio G; Serra S; Duarte C; Ferreira RJO; da Silva JAPD
    Joint Bone Spine; 2021 Dec; 88(6):105242. PubMed ID: 34166795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.